Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 08 Dec 2022 |
2 | Reply to Exam Report (MIS-R) | 29 Jul 2023 |
3 | Journal Copy | 17 Nov 2023 |
4 | TM-O(NOTICE OF OPPOSITION) | 02 Dec 2023 |
5 | TM-O(NOTICE OF OPPOSITION) | 11 Dec 2023 |
1 | EXAMINATION REPORT | 15468902 | 21 Jun 2023 | |
2 | Opposition Notice | 16742418 | 6374338 | 06 Dec 2023 |
3 | Opposition Notice | 16837227 | 6394538 | 15 Dec 2023 |
4 | Order Form of 21(2) | 18237828 | 6742616 | 30 May 2024 |
5 | Order Form of 21(2) | 18237829 | 6742612 | 30 May 2024 |
The application for Clotrimax ovules was made on 08 December 2022.
The trademark applicant for Clotrimax ovules is BLISS GVS PHARMA.
Clotrimax ovules is applied in class(es) 5.
Application for Clotrimax ovules is on Abandoned stage.
Application Id allotted to Clotrimax ovules is 5713758.
Trademark agent or attorney for the application is Innovative Consultants.
Clotrimax ovules filed with the Intellectual property office as a DEVICE.